NCT05630456

Brief Summary

The Effect of Health Provider's Feedback on Physical Activity Surveillance using Wearable Device-Smartphone Application for Resolution of Metabolic Syndrome; a 12-Week Randomized Control Study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 29, 2022

Completed
Last Updated

November 29, 2022

Status Verified

November 1, 2022

Enrollment Period

6 months

First QC Date

October 24, 2022

Last Update Submit

November 27, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Fasting blood tests on baseline and 12th week visits

    Blood samples were collected from the Jeonju vein after fasting for 6 hours and analyzed in our hospital's laboratory. The lipid profile was tested using an automated analyzer (Hitachi 747, Hitachi Corp, Japan) and enzyme colorimetric method. FPG levels were evaluated using glucose oxidase methods and Synchron LX 20 (Beckman Coulter, Fullerton, CA)

    Baseline and 12week

  • Changes in blood pressure (systolic blood pressure, diastolic blood pressure) at baseline and 12 weeks

    Blood pressure was measured in a sitting position after resting using BP-203 RVII(Colin Corp, Aichi, Japan)

    Baseline and 12week

  • Changes in waist circumference (cm) at baseline and 12 weeks

    The waist circumference was evaluated by a trained examiner (after normal exhalation) to the nearest millimeter from the midpoint between the lower edge of the rib and the iliac ridge.

    Baseline and 12week

  • Measurement of physical activity through wearable devices

    Investigators provided with wrist-wearable device (B.BAND, B Life Inc, Korea), which allowed them to wear and live for 12 weeks. Subsequently, a compatible app was installed on the participants' mobile phones and connected to a wearable device. Researchers who have been granted access can check and track participants' steps, calorie consumption, and MVPA (moderate- to vigorousintensity physical activity) on a daily basis through a web page.

    For 12 weeks

Secondary Outcomes (1)

  • Changes in body composition at baseline and 12 weeks

    Baseline and 12week

Other Outcomes (2)

  • Gathering subject information from the survey

    Baseline

  • Satisfaction of using wearable-smartphone apps using visual analog scale (VAS)

    At 12th week

Study Arms (2)

Intervention Group

EXPERIMENTAL

In the intervention group, the researcher gave feedback on the subjects' exercise amount through telephone contact every 2 weeks during the 12-week study period. Through phone consultations, they answered questions about exercise or discussed problems, encouraged to continue exercising, answered questions or discussed problems related to wearable devices and apps, and encouraged continuous data transmission.

Other: Receving feedback

Control Group

PLACEBO COMPARATOR

In the case of the control group, physical activity is monitored by itself through wearable devices and smartphone apps without phone counseling.

Other: No regular feedback

Interventions

Receving regular feedback from a health provider

Intervention Group

No regular feedback from a health provider

Control Group

Eligibility Criteria

Age19 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smart phone user

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Hospital

Busan, Seo-gu, 49241, South Korea

Location

MeSH Terms

Conditions

Metabolic SyndromeMotor Activity

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: In the intervention group, the researcher provided feedback on the participants' exercise amount through telephone contact every two weeks during the 12-week study period. It includes recommendations for continuing exercise therapy based on the recommendations for physical activity. Through phone consultations, they answered questions about exercise or discussed problems, were encouraged to continue exercising, answered questions or discussed problems related to wearable devices and apps, and encouraged for continuous data transmission.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 24, 2022

First Posted

November 29, 2022

Study Start

August 1, 2020

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

November 29, 2022

Record last verified: 2022-11

Locations